Position in GRAL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$392,552
New position
Shares Held
5,750
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#160
of 371 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Yorktown Management & Research Co Inc holds $4,944,899 across 7 Diagnostics & Research names. GRAL ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
12,500 | $1,875,375 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
1,800 | $953,262 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,100 | $524,688 | |
| 4 | VCYT |
Veracyte, Inc.
|
7,750 | $455,157 | |
| 5 | BLLN |
BillionToOne, Inc.
|
3,450 | $413,931 | |
| 6 | GRAL |
GRAIL, Inc.
This page
|
5,750 | $392,552 | |
| 7 | RDNT |
RadNet, Inc.
|
5,350 | $329,934 |
All Filings in GRAL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,552 | 5,750 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||